Redefining the immune landscape of hepatitis A virus infection

Abstract

Despite the development of effective vaccines against hepatitis A virus (HAV) infection, outbreaks of acute hepatitis A still occur globally, such that HAV remains a major cause of acute viral hepatitis. Most patients with acute hepatitis A recover spontaneously; however, some adult cases result in acute liver failure due to immune-mediated liver damage. Previous studies suggested that HAV evades the innate immune response through strong counteractive mechanisms, and that HAV-specific CD8+ T cells contribute to liver damage in patients with acute hepatitis A. However, recent research findings have led to revisions of old hypotheses. Here we will describe the most current knowledge regarding the innate immune response to HAV and the HAV-mediated counteractions against innate immune responses. Additionally, we will discuss the roles of various types of T cells in viral clearance and liver injury in patients with acute hepatitis A. Hepatitis A virus (HAV) is a small virus that causes liver infections, often spread through contaminated food and water. Despite effective vaccines, understanding how HAV interacts with the immune system is crucial. This study focuses on how HAV triggers the immune system and how this can lead to liver damage. The authors used cell cultures and animal models to study the effects of HAV and found that HAV can activate certain immune cells, such as CD8+ T cells, which can attack liver cells, causing damage. This activation is partly due to IL-15, which boosts immune cell activity. The results show that while the immune response helps clear the virus, it can also harm the liver. The researchers conclude that balancing this response is key to managing HAV infections. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.